SS&H Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.19M Hold
2,034
0.64% 41
2025
Q3
$1.55M Buy
2,034
+800
+65% +$595K 0.47% 54
2025
Q2
$962K Buy
1,234
+100
+9% +$77.7K 0.32% 63
2025
Q1
$937K Hold
1,134
0.35% 65
2024
Q4
$876K Buy
1,134
+175
+18% +$145K 0.32% 70
2024
Q3
$850K Buy
959
+122
+15% +$110K 0.31% 73
2024
Q2
$757K Hold
837
0.3% 74
2024
Q1
$651K Hold
837
0.27% 77
2023
Q4
$488K Hold
837
0.21% 89
2023
Q3
$450K Buy
+837
New +$431K 0.21% 90
2023
Q1
$284K Hold
826
0.13% 112
2022
Q4
$302K Hold
826
0.14% 104
2022
Q3
$267K Hold
826
0.14% 109
2022
Q2
$268K Sell
826
-250
-23% -$75K 0.12% 114
2022
Q1
$308K Buy
+1,076
New +$277K 0.12% 118

Other funds holding LLY

SS&H Financial Advisors's LLY Position: Q4 2025 in Review

SS&H Financial Advisors held its Eli Lilly (LLY) position steady in Q4 2025 at 2,034 shares worth $2.19M. The position accounts for 0.64% of the portfolio, ranked #41.

SS&H Financial Advisors first reported a position in LLY in Q1 2022 and has held it in 15 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • SS&H Financial Advisors held 2,034 shares of Eli Lilly worth $2.19M as of Q4 2025.
  • SS&H Financial Advisors left its Eli Lilly share count unchanged in Q4 2025.
  • Eli Lilly made up 0.64% of SS&H Financial Advisors's portfolio in Q4 2025, its #41 holding.
  • SS&H Financial Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 15 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on SS&H Financial Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.